STVN logo

Stevanato Group S.p.A. (STVN)

Profile

Full Name

Stevanato Group S.p.A.

Ticker

NYSE: STVN

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Italy

IPO

July 16, 2021

Indexes

Not included

Website

http://www.stevanatogroup.com

Employees

5521

Key Details

Price

$26.51(-5.15%)

Market cap

$7.23B(Mid cap)

Last Dividend

$0.06

TTM Dividend yield

0.23%

Annual revenue

$1.19B(+1.70% YoY)

Annual EPS

$0.47(-21.83% YoY)

PE ratio

52.58

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $26.51
    STVN price is $26.51

    30-Day Relative Volume

    1.34
    STVN 30-day relative volume is 1.34

    Price Performance

    Price Most recent change

    -5.15%
    STVN price was down -5.15% on Jul 25, 2025

    Price YTD change

    +21.66%
    STVN price is up +21.66% since January 1st

    Price 1-year change

    +33.96%
    STVN price is up +33.96% year-on-year

    Price 3-year change

    +64.35%
    STVN price is up +64.35% over the past 3 years

    Price Range

    Price All-time high

    $36.30
    STVN price is currently -26.97% below its historical high of $36.30

    Price 3-year low

    $13.71
    STVN price is currently +93.36% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $7.23B
    STVN market capitalization is $7.23 billion

    Market cap 3-year change

    +69.44%
    STVN market capitalization is up +69.44% over the past 3 years

    Market cap All-time high

    $9.39B
    STVN market capitalization is currently -22.99% below its historical high of $9.39 billion

    Market cap sector rank

    90.6%
    STVN market capitalization is higher than 90.6% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.02%
    STVN shares outstanding is up +0.02% year-on-year

    Shares Outstanding 3-Year Change

    +3.1%
    STVN shares outstanding is up +3.1% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.67
    STVN beta is 0.67

    200-day SMA

    $21.68
    STVN price is currently +22.28% above its 200-day simple moving average

    50-day SMA

    $24.22
    STVN price is currently +9.44% above its 50-day simple moving average

    RSI

    58.68
    STVN 14-day relative strength index is 58.68

    Volume

    1.34
    STVN 30-day relative volume is 1.34

    ATR

    $1.35
    STVN average true range is $1.35

    10-day Historical Volatility

    66.07%
    STVN 10-day historical volatility is 66.07%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.06
    STVN last dividend was $0.06 per share, with an ex-dividend date of June 5, 2025

    Next Dividend

    -
    STVN next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $0.06
    STVN annual dividend per share is $0.06

    Dividend per share Sector Rank

    1.18%
    STVN annual dividend per share is higher than 1.18% of companies in Healthcare sector

    Dividend per share 1-Year Change

    0%
    STVN annual dividend per share has remained unchanged year-on-year

    Dividend per share 3-Year Change

    -
    STVN annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    0.22%
    STVN annual dividend yield is 0.22%

    Dividend yield Sector Rank

    2.38%
    STVN annual dividend yield is higher than 2.38% of companies in Healthcare sector

    Other

    Payout ratio

    12.27%
    STVN annual payout ratio is 12.27%

    Dividends paid

    $15.65M
    STVN annual dividends paid is $15.65 million

    Free cash flow

    -$170.79M
    STVN annual free cash flow is -$170.79 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $1.19B
    STVN annual revenue is $1.19 billion

    Revenue Analysts estimate

    $1.18B
    STVN annual revenue is currently +1.62% higher than the consensus analysts' forecast

    Revenue 1-year change

    +1.7%
    STVN annual revenue is up +1.7% year-on-year

    Revenue Sector rank

    81.6%
    STVN annual revenue is higher than 81.6% of companies in Healthcare sector

    EPS

    EPS

    $0.47
    STVN annual earnings per share is $0.47

    EPS Analysts estimate

    $0.61
    STVN annual earnings per share is currently -23.40% lower than the consensus analysts' forecast

    EPS 1-year change

    -21.83%
    STVN annual earnings per share is down -21.83% year-on-year

    EPS Sector rank

    86.72%
    STVN annual earnings per share is higher than 86.72% of companies in Healthcare sector

    Profit

    Gross profit

    $327.21M
    STVN annual gross profit is $327.21 million

    Gross margin

    27.38%
    STVN annual gross profit margin is 27.38%

    Operating profit

    $174.41M
    STVN annual operating income is $174.41 million

    Operating margin

    14.60%
    STVN annual operating profit margin is 14.60%

    Net income

    $127.48M
    STVN annual net profit is $127.48 million

    Net margin

    10.67%
    STVN annual net profit margin is 10.67%

    Expenses

    Total expenses

    $1.02B
    STVN annual total expenses is $1.02 billion

    Operating expenses

    $152.80M
    STVN annual total operating expenses is $152.80 million

    Cost of goods sold

    $867.74M
    STVN annual cost of goods sold is $867.74 million

    Selling, general & administrative expenses

    $128.37M
    STVN annual SGA is $128.37 million

    Depreciation and amortization

    $87.29M
    STVN annual depreciation & amortization is $87.29 million

    Interest expense

    $7.43M
    STVN annual interest expense is $7.43 million

    Income tax

    $46.02M
    STVN annual income tax is $46.02 million

    EBIT & EBITDA

    EBIT

    $180.92M
    STVN annual earnings before interest & taxes is $180.92 million

    EBITDA

    $268.21M
    STVN annual EBITDA is $268.21 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $2.42B
    STVN annual total assets is $2.42 billion

    Non current assets

    $1.51B
    STVN annual long term assets is $1.51 billion

    Current assets

    $915.83M
    STVN annual total current assets is $915.83 million

    Cash and cash equivalents

    $102.26M
    STVN annual cash & cash equivalents is $102.26 million

    Accounts receivable

    $307.96M
    STVN annual accounts receivable is $307.96 million

    Inventory

    $255.17M
    STVN annual inventory is $255.17 million

    Liabilities

    Total liabilities

    $961.94M
    STVN annual total liabilities is $961.94 million

    Long term liabilities

    $465.09M
    STVN annual total long term liabilities is $465.09 million

    Current liabilities

    $496.85M
    STVN annual total current liabilities is $496.85 million

    Accounts payable

    $240.39M
    STVN annual accounts payable is $240.39 million

    Debt

    Total debt

    $446.37M
    STVN annual total debt is $446.37 million

    Total debt 1-year change

    +1.82%
    STVN annual total debt is up +1.82% year-on-year

    Long term debt

    $329.90M
    STVN annual long term debt is $329.90 million

    Short term debt

    $116.48M
    STVN annual short term debt is $116.48 million

    Equity & Capital

    Shareholders equity

    $1.46B
    STVN annual stockholders equity is $1.46 billion

    Book value

    $1.46B
    STVN annual book value is $1.46 billion

    Retained earnings

    $898.47M
    STVN annual retained earnings is $898.47 million

    Working capital

    $418.98M
    STVN annual working capital is $418.98 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $168.60M
    STVN annual cash flow from operations is $168.60 million

    Cash from operations 1-year change

    +48.03%
    STVN annual cash flow from operations is up +48.03% year-on-year

    Cash from investing

    -$335.76M
    STVN annual cash flow from investing activities is -$335.76 million

    Cash from investing 1-year change

    +26.37%
    STVN annual cash flow from investing activities is up +26.37% year-on-year

    Cash from financing

    $198.31M
    STVN annual cash flow from financing activities is $198.31 million

    Cash from financing 1-year change

    +15.91%
    STVN annual cash flow from financing activities is up +15.91% year-on-year

    CAPEX

    CAPEX

    $339.39M
    STVN annual capital expenditures is $339.39 million

    CAPEX 1-year change

    -29.06%
    STVN annual capital expenditures is down -29.06% year-on-year

    Free Cash Flow

    Free cash flow

    -$170.79M
    STVN annual free cash flow is -$170.79 million

    Free cash flow 1-year change

    +53.15%
    STVN annual free cash flow is up +53.15% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    27.38%
    STVN annual gross profit margin is 27.38%

    Operating margin

    14.60%
    STVN annual operating profit margin is 14.60%

    Net margin

    10.67%
    STVN annual net profit margin is 10.67%

    ROA & ROE

    ROA

    5.41%
    STVN annual return on assets is 5.41%

    ROE

    9.40%
    STVN annual return on equity is 9.40%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    52.58
    STVN price to earnings ratio is 52.58

    PE ratio Sector rank

    80.66%
    STVN price to earnings ratio is higher than 80.66% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.72
    STVN price to book ratio is 4.72

    PB ratio Sector rank

    78.33%
    STVN price to book ratio is higher than 78.33% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.99
    STVN price to sales ratio is 5.99

    PS ratio Sector rank

    66%
    STVN price to sales ratio is higher than 66% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $7.56B
    STVN enterprise value is $7.56 billion

    Enterprise value Sector rank

    90.33%
    STVN enterprise value is higher than 90.33% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    25.16
    STVN EV/EBITDA is 25.16

    EV/EBITDA Sector rank

    93.57%
    STVN EV/EBITDA is higher than 93.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.84
    STVN annual current ratio is 1.84

    Quick ratio

    1.33
    STVN annual quick ratio is 1.33

    Leverage

    Debt to equity

    0.29
    STVN annual debt to equity ratio is 0.29

    Interest coverage ratio

    24.35
    STVN annual interest coverage ratio is 24.35

    Risk & Stability

    Piotroski F-Score

    5
    STVN piotroski f-score is 5

    Altman Z-Score

    5.98
    STVN altman z-score is 5.98

    Analyst ratings

    Recent major analysts updates

    Mar 7, 25 UBS
    Neutral
    Dec 13, 24 Wolfe Research
    Outperform
    Dec 13, 24 B of A Securities
    Buy
    Aug 7, 24 Citigroup
    Buy
    Jul 15, 24 Morgan Stanley
    Equal-Weight
    Apr 22, 24 Morgan Stanley
    Equal-Weight
    Mar 25, 24 Stephens & Co.
    Overweight
    Nov 1, 23 Morgan Stanley
    Equal-Weight
    Nov 1, 23 Jefferies
    Hold
    Sep 26, 23 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with STVN included

    Growing Shares Outstanding
    Mid cap stocks
    Best performing stocks last 3 months
    Stocks above SMA 50
    Healthcare sector
    All stocks
    High Altman Z score stocks
    Best performing stocks YTD
    Ex Dividend dates calendar
    NYSE Companies
    • What is the ticker symbol for Stevanato Group S.p.A.?
    • Does Stevanato Group S.p.A. pay dividends?
    • What sector is Stevanato Group S.p.A. in?
    • What industry is Stevanato Group S.p.A. in?
    • What country is Stevanato Group S.p.A. based in?
    • When did Stevanato Group S.p.A. go public?
    • Is Stevanato Group S.p.A. in the S&P 500?
    • Is Stevanato Group S.p.A. in the NASDAQ 100?
    • Is Stevanato Group S.p.A. in the Dow Jones?
    • When was Stevanato Group S.p.A.'s last earnings report?
    • When does Stevanato Group S.p.A. report earnings?

    What is the ticker symbol for Stevanato Group S.p.A.?

    The ticker symbol for Stevanato Group S.p.A. is NYSE:STVN

    Does Stevanato Group S.p.A. pay dividends?

    Yes, Stevanato Group S.p.A. pays dividends. The last payment was $0.06, with an ex-dividend date on June 5, 2025

    What sector is Stevanato Group S.p.A. in?

    Stevanato Group S.p.A. is in the Healthcare sector

    What industry is Stevanato Group S.p.A. in?

    Stevanato Group S.p.A. is in the Medical Instruments & Supplies industry

    What country is Stevanato Group S.p.A. based in?

    Stevanato Group S.p.A. is headquartered in Italy

    When did Stevanato Group S.p.A. go public?

    Stevanato Group S.p.A.'s initial public offering (IPO) was on July 16, 2021

    Is Stevanato Group S.p.A. in the S&P 500?

    No, Stevanato Group S.p.A. is not included in the S&P 500 index

    Is Stevanato Group S.p.A. in the NASDAQ 100?

    No, Stevanato Group S.p.A. is not included in the NASDAQ 100 index

    Is Stevanato Group S.p.A. in the Dow Jones?

    No, Stevanato Group S.p.A. is not included in the Dow Jones index

    When was Stevanato Group S.p.A.'s last earnings report?

    Stevanato Group S.p.A.'s most recent earnings report was on May 8, 2025

    When does Stevanato Group S.p.A. report earnings?

    The next expected earnings date for Stevanato Group S.p.A. is August 5, 2025
    On this page